Organization & Leadership

To accomplish its mission, SCB operates in partnership with industry, academia, government agencies, regulatory bodies, and standards development organizations (SDOs) involved in establishing consensus standards for regenerative medicine and other advanced therapy products.

SCB’s leadership guides the organization in its mission to coordinate the accelerated advancement of standards for the regenerative medicine community.


Executive Committee

richard mcfarland

Richard McFarland

President

Jessica Carmen

Jessica Carmen

Vice President

april lynch

April Lynch

Secretary

michael orrico

Michael Orrico

Treasurer


Board of Directors

JESSICA CARMEN, Adjuvant Partners

KURT GUNTER, Kuur Therapeutics

NAYNESH KAMANI

MIKE KELLY, Atsena Therapeutics

SVEN KILI, Sven Kili Consulting

MIKE LEHMICKE, Alliance for Regenerative Medicine (ARM)

APRIL LYNCH, CSafe Global

JENNIFER MANTLE, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

RICHARD MCFARLAND, Advanced Regenerative Manufacturing Institute (ARMI)

MICHAEL MENDICINO, Hybrid Concepts International

MICHAEL ORRICO, Shepherd Payne Associates

ERIC ROOS, Aspect Biosystems

KRISHNENDU ROY, Georgia Institute of Technology

MORRIE RUFFIN, Adjuvant Partners

MITCH SIVILOTTI, CCRM

JASON WERTHEIM, University of Arizona College of Medicine - Tucson

ELIZABETH S. WOO, Thermo Fisher Scientific

YUTAKA YANAGITA, Forum for Innovative Regenerative Medicine (FIRM)

JIWEN ZHANG, Renovacor

CLAUDIA ZYLBERBERG, Akron Biotech

SCB LIAISONS

SHENG-LIN GIBSON, National Institute of Standards and Technology (NIST)

ANNE PLANT, National Institute of Standards and Technology